Elizabeth A Musgrove

Summary

Affiliation: Garvan Institute of Medical Research
Country: Australia

Publications

  1. ncbi Distinct and redundant functions of cyclin E1 and cyclin E2 in development and cancer
    C Elizabeth Caldon
    Cancer Research Program, Garvan Institute of Medical Research, Sydney, NSW 2010, Australia
    Cell Div 5:2. 2010
  2. ncbi CDK inhibitors as potential breast cancer therapeutics: new evidence for enhanced efficacy in ER+ disease
    Robert L Sutherland
    Cancer Research Program, Garvan Institute of Medical Research, 384 Victoria Street, Darlinghurst, Sydney, NSW 2010, Australia
    Breast Cancer Res 11:112. 2009

Collaborators

  • C Elizabeth Caldon
  • Robert L Sutherland

Detail Information

Publications2

  1. ncbi Distinct and redundant functions of cyclin E1 and cyclin E2 in development and cancer
    C Elizabeth Caldon
    Cancer Research Program, Garvan Institute of Medical Research, Sydney, NSW 2010, Australia
    Cell Div 5:2. 2010
    ..This is supported by in vitro data identifying divergent regulation of the two genes, as well as potentially different roles in vivo...
  2. ncbi CDK inhibitors as potential breast cancer therapeutics: new evidence for enhanced efficacy in ER+ disease
    Robert L Sutherland
    Cancer Research Program, Garvan Institute of Medical Research, 384 Victoria Street, Darlinghurst, Sydney, NSW 2010, Australia
    Breast Cancer Res 11:112. 2009
    ....